tracking cancer drugs living cells thermal profiling proteome 
thermal stability proteins can used assess ligand binding living cells generalized concept determining thermal profiles proteins human cells means mass spectrometry monitoring effects small-molecule ligands profiles delineated targets kinase inhibitor staurosporine identified heme biosynthesis enzyme ferrochelatase target kinase inhibitors suggest inhibition causes phototoxicity observed vemurafenib alectinib thermal shifts also observed downstream effectors drug treatment live cells dasatinib induced shifts bcr-abl pathway proteins including crk/crkl thermal proteome profiling provides unbiasedmeasure drug-target engagement facilitates identification markers drug efficacy toxicity 
